Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Department
Adjust height of sidebar
KMap
Department
Asthma & Airway Disease Research Center
34 active people
24 grants
Recent Grants
A Multicentre, Randomised, Double-blind, Parallel Group,Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients with Severe Eos
2023
·
$2.9M
asthma,
pediatric patients,
clinical trial,
drug treatment
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase II Study to Assess the Efficacy and Safety of Daily OM-85 Treatment Versus Placebo Given on Top of Standard of Care in Children Aged
2023
·
$814.9K
clinical trial,
immunotherapy,
pediatric medicine,
respiratory health,
drug efficacy
CFF Data and Safety Monitoring Board
2023
·
$551.3K
clinical trials,
data monitoring,
safety,
healthcare regulation,
medical ethics
A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of Epicutaneous lmmunotherapy with DBV712 250 ?g in 4-7-year-old Children with Peanut Allergy (VITESSE)
2023
·
$397.9K
immunotherapy,
peanut allergy,
efficacy,
safety,
children
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF (STRONG-CF)
2023
·
$292K
nutrition,
lung function,
muscle strength,
cystic fibrosis,
outcomes
Systemic and Intercellular Gene Networks Underlying RV-Induced Airways Disease
2023
·
$268.6K
gene networks,
respiratory viral infection,
cellular communication,
airway disease,
systemic effects
A Randomised, Double-blind, Parallel Group Phase III Study To Assess The Efficacy And Safety Of 100 Mg Sc Depemokimab In Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Anchor 2 Depem
2023
·
$203.2K
chronic rhinosinusitis,
nasal polyps,
efficacy,
safety
A Phase I Clinical Trial to Evaluate the Safety and Tolerability of VLP Peanut in Healthy Subjects and Subjects With Peanut Allergy and to Explore Preliminary Signals of Its Efficacy (PROTECT)
2023
·
$137.8K
clinical trials,
peanut allergy,
vaccine,
safety,
efficacy
Standardizing Treatments for Pulmonary Exacerbations: A platform for evaluating treatment decisions to improve outcomes (STOP360)
2023
·
$125.2K
pulmonary exacerbations,
treatment standardization,
evaluation platform,
treatment decisions,
outcomes improvement
Food Allergy patient Samples (OATS)
2023
·
$61.1K
food allergy,
patient samples,
oats,
medical research,
immunology
Development of SP-A-Derived Peptidomimetics for the Treatment of Asthma - Phase II
2022
·
$1M
peptidomimetics,
asthma,
sp-a-derived,
treatment,
development
Therapeutics Development Center Award
2022
·
$298.8K
therapeutics,
development,
center,
award,
medical research
Innate Immunity and Viral Infection in Asthma
2021
·
$4.3M
innate immunity,
viral infection,
asthma,
immune response,
respiratory health
1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)
2021
·
$3.5M
respiratory infections,
pediatric medicine,
antibiotic treatment,
emergency medicine,
clinical trials
Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life
2020
·
$6M
chronic lung disease,
early origins,
long-term outcomes,
respiratory health,
childhood risk factors
Beyond Pseudotime: Enhanced Single-cell GEnomics Tools for Understanding the Temporal Dynamics of Development and Disease
2020
·
$1.5M
single-cell genomics,
temporal dynamics,
development,
disease,
enhanced tools
Effect of OM-85-BV in an OVA Model of Asthma: A Comprehensive Dose-Response Study
2017
·
$11.4M
asthma,
immunotherapy,
dose-response,
om-85-bv,
inflammation
American Lung Association Asthma Clinical Research Center (ALA-ACRC)
2016
·
$1.2M
asthma,
clinical research,
roflumilast,
lung health,
treatment trial
American Lung Association Asthma Clinical Research Center (ALA-ACRC)
2016
·
$89K
asthma,
clinical research,
roflumilast,
lung health,
treatment trial
BI Lung Health Cohort (LHC) Supplement Grant
2016
·
$25.4K
asthma,
clinical research,
roflumilast,
lung health,
treatment trial
People
Avery DeVries
Researcher/Scientist III
Ashley Michael
Research Technologist II
Amber Spangenberg
Research Specialist, Principal
Elizabeth Firmage
Administrative Operations Manager IV
Elvira Begay
Research Professional I
Bruce Saul
Database Administrator II
Clara Ehrman
Research Program Administration Officer I
Dayna Anderson
Research Technologist II
Debra Stern
Data Scientist Manager III
Destiny Hessel
Research Technician II
David Spies
Applications Systems Analyst/Developer, Senior
Elia Cornidez
Clinical Research Coordinator III
Elizabeth Ryan
Clinical Research Coordinator III
Erin Cool
Accounting Manager I
Eva Barrow
Administrative Support Assistant II
Glenda Jerezano
Administrative Support Professional I
Hyunjin Kang
Research Professional II
Jaesa Strong
Research Compliance Administrator III
Janell Merchen
Nurse Practitioner III
James Read
Data Scientist IV
Leslie Hargrove
Website Administrator II
Meg Rother-Gossmann
Administrative Operations HR Support Pro III
Michele Simon
Grant and Contract Administrator II
Megan Peterson
Research Nurse II
Nirushan Narendran
Clinical Research Coordinator III
Oksana Pivniouk
Research Laboratory Manager I
Osmara Molina de Rodriguez
Clinical Research Manager II
Sheilah Allison
Research Technician III
Samantha Banchy
Clinical Research Coordinator II
Seongmin Hahn
Research Technologist II
Silvia Lopez
Research Nurse III
Sunil Banskar
Researcher/Scientist III
Zachary Stetson
App Develop Prgmer Analyst I
Melissa Campos
Clinical Research Coordinator I